Project Details
Description
A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of LAVA-1207, a PSMA targeting bispecific gamma...
| Status | Finished |
|---|---|
| Effective start/end date | 10/28/24 → 7/2/25 |
Funding
- LAVA THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.